Despite that previous studies found the suppressing role of anti-VEGF/EGFR antibody on CRC development [35, 36], the potential effect of combination anti-VEGF and anti-EGFR antibodies on CRC growth and angiogenesis remains little known. This evidence concerns the gene EGFR and colorectal carcinoma.